[{"Assets_0_Q2_USD":51210000.0,"CommonStockSharesOutstanding_0_Q2_shares":15645545.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-5982000.0,"NetIncomeLoss_2_Q2_USD":-7308000.0,"NetIncomeLoss_1_Q2_USD":-3026000.0,"StockholdersEquity_0_Q2_USD":49821000.0,"Ticker":"BTAI","CIK":"1720893","name":"BIOXCEL THERAPEUTICS, INC.","OfficialName":"BioXcel Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"417746551.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]